The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.075
Bid: 17.60
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 0.90 (5.114%)
Open: 18.075
High: 0.00
Low: 0.00
Prev. Close: 18.075
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

17 Jun 2009 07:00

RNS Number : 9968T
BATM Advanced Communications Ld
17 June 2009
 



17 June 2009

BATM Advanced Communications Limited

AGM Statement

At the AGM of the Company, which is due to be held at 11am today, Peter Sheldon, Chairman of BATM, will make the following statement: 

"I would like to take this opportunity to update shareholders on the continued progress that we are making in the current financial year. Despite the very challenging market conditions, the current pattern of our trading and forward order book gives us confidence that we will achieve our targets for the year. 

"The first half of the last financial year was exceptionally strong, benefitting from increased business from the Olympic Games.  In comparison, in the first half of the current financial year we expect to achieve a level of revenues broadly similar to the more representative second half of last year, albeit with a slightly lower level of profitability due principally to foreign currency fluctuations.  The Company continues to deploy its products in numerous projects around the globe and has achieved several recent important contract wins. There has been a noticeable improvement in the Company's order book in the last couple of months, particularly relating to increasing business in the Far East

"Our programme of integrating the newer acquisitions with the rest of Group is realising synergies in all of our business lines. We continue to innovate in the Telecoms, Medical Devices and Surveillance fields, and to offer our existing and new customers technologically superior product offerings.

"I hope that shareholders will increasingly recognise that the investments that we have made in technology, infrastructure and, most importantly, our customers during these challenging times have been well judged and we expect these investments to continue to strengthen our prospects for the future.

"I would like to congratulate the whole BATM team for their dedication, enterprise and innovation that has enabled the Company to reinforce and maintain the position that it now enjoys."

- ends -

Enquiries

BATM Advanced Communications

Dr Zvi Marom, Chief Executive

+972 9866 2525

Threadneedle Communications

Josh Royston / Graham Herring

020 7653 9850

Singer Capital Markets Ltd

Nicholas How

020 3205 7620 

Shore Capital

Graham Shore

020 7408 4090 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUNAVRKURNAAR
Date   Source Headline
26th May 20227:00 amRNSBlock Listing Interim Review
14th Apr 20229:30 amRNSAnnual Financial Report
13th Apr 20227:00 amRNSAppointment of Non-Executive Director
4th Apr 20227:00 amRNSTransaction in Own Shares and TVR
18th Mar 20227:00 amRNSStrategic Partnership for Edgility with NEXCOM
17th Mar 202210:30 amRNSResult of General Meeting
10th Mar 202212:30 pmRNSHolding(s) in Company
8th Mar 202211:30 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSFull Year Results
23rd Feb 20227:00 amRNSNotice of General Meeting
21st Feb 20227:00 amRNSStrategic Partnership for Edgility with Advantech
17th Feb 20227:00 amRNSTrading Update and Notice of Results
3rd Feb 202211:23 amRNSClarification on FTSE Nationality Review
3rd Feb 20227:00 amRNSUpdate on FTSE Nationality Review & Share Buyback
31st Jan 20227:00 amRNSUpdate on Ador Diagnostics
17th Jan 20227:00 amRNSUpdate on FTSE Nationality Review
4th Jan 20227:00 amRNSDividend Declaration
4th Jan 20227:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSFirst sales of rapid COVID-19 test in Russia
14th Dec 202111:45 amRNSResult of AGM and Dividend Declaration
30th Nov 20217:00 amRNSCOVID-19 tests effective in diagnosing Omicron
25th Nov 20213:00 pmRNSBlock Listing Interim Review
22nd Nov 20213:00 pmRNSNotice of AGM and Dividend Declaration
10th Nov 20217:00 amRNSBATM receives $3.5m cyber security contract
3rd Nov 20217:00 amRNSNew five-year contract for Edgility
1st Nov 20217:00 amRNSBATM receives agri-waste contract in Botswana
7th Oct 20217:00 amRNSStrategic partnership for NFV with AudioCodes
13th Sep 20217:00 amRNSFirst enterprise customer for NFV with $2m order
23rd Aug 20217:00 amRNSInterim Results
12th Aug 20217:00 amRNSNotice of Results
12th Jul 20217:00 amRNSLaunch of Edgility networking NFV-based ecosystem
5th Jul 20217:00 amRNSBATM receives $10m cyber security contract
15th Jun 20217:00 amRNSBATM receives $4.1m cyber security contract
26th May 20217:00 amRNSBlock listing Interim Review
18th May 20217:00 amRNSBATM commences delivery of new COVID-19 tests
19th Apr 202110:25 amRNSAnnual Financial Report
12th Apr 20217:00 amRNSStrategic partnership for NFV
29th Mar 20217:00 amRNSBATM develops molecular diagnostics test for TB
19th Mar 20217:00 amRNSCompletion of Sale of NGSoft
11th Mar 20217:00 amRNSBATM launches no-swab saliva-based COVID-19 test
1st Mar 20217:00 amRNSUpdate on Sale of NGSoft
22nd Feb 20217:00 amRNSFull Year Results
11th Feb 20215:38 pmRNSFTSE Nationality Review
1st Feb 20217:00 amRNSTrading Update and Notice of Results
19th Jan 20217:00 amRNSBATM's NFVTime now available for the public cloud
12th Jan 20217:00 amRNSBATM enters option agreement to sell NGSoft
24th Dec 20207:00 amRNSCOVID-19 test effective in diagnosing new strain
17th Dec 20203:50 pmRNSResult of AGM
15th Dec 20207:00 amRNSUpdate on Ador Diagnostics
7th Dec 20207:00 amRNSDelivery of First Insect Protein Recovery Facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.